More NewsRead More
Rodman & Renshaw Updates Analyst Report on RegeneRx Biopharmaceuticals, Inc. with Buy Rating
May 10, 2016
RegeneRx to Receive EU Patent for Use of T?4 in Preventing And Treating Damage Associated with Reperfusion Injury
April 06, 2016
Rodman & Renshaw Initiates Coverage of RegeneRx Biopharmaceuticals, Inc. with Buy Rating
March 14, 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
January 29, 2016
RegeneRx U.S. Joint Venture, ReGenTree, Launches Web Site
January 28, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here